Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Tumour Necrosis Factor Inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases.

Thomas ML, Shaddick G, Charlton R, Cavill C, Holland R, Iannone F, Lapadula G, Lopriore S, Závada J, Uher M, Pavelka K, Szczukova L, Sidiropolous P, Flouri I, Drosos A, Möller B, Nissen MJ, Müller RB, Scherer A, McHugh N, Nightingale A.

J Rheumatol. 2020 Apr 1. pii: jrheum.190815. doi: 10.3899/jrheum.190815. [Epub ahead of print]

PMID:
32238520
2.

Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress.

Kozlik P, Hasikova L, Stiburkova B, Zavada J, Kalikova K.

Anal Biochem. 2020 Jan 15;589:113509. doi: 10.1016/j.ab.2019.113509. Epub 2019 Nov 17.

PMID:
31747555
3.

Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.

Tužil J, Mlčoch T, Jirčíková J, Závada J, Nekvindová L, Svoboda M, Uher M, Křístková Z, Vencovský J, Pavelka K, Doležal T.

Expert Opin Biol Ther. 2020 Feb;20(2):183-192. doi: 10.1080/14712598.2020.1694900. Epub 2019 Nov 25.

PMID:
31736377
4.

Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I).

Skougaard M, Bliddal H, Christensen R, Ellegaard K, Nielsen SM, Zavada J, Oreska S, Krogh NS, Holm CC, Hetland ML, Vencovsky J, Røgind H, Taylor PC, Gudbergsen H.

J Rheumatol. 2019 Aug 15. pii: jrheum.181362. doi: 10.3899/jrheum.181362. [Epub ahead of print]

PMID:
31416921
5.

Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.

Hasikova L, Pavlikova M, Hulejova H, Kozlik P, Kalikova K, Mahajan A, Herrmann M, Stiburkova B, Zavada J.

Rheumatol Int. 2019 Oct;39(10):1749-1757. doi: 10.1007/s00296-019-04394-6. Epub 2019 Jul 31.

PMID:
31363829
6.

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H, Lioté F, Mallen CD, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell A, So AK, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T.

Ann Rheum Dis. 2020 Jan;79(1):31-38. doi: 10.1136/annrheumdis-2019-215315. Epub 2019 Jun 5.

PMID:
31167758
7.

EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review.

Prevolnik Rupel V, Divjak M, Zrubka Z, Rencz F, Gulácsi L, Golicki D, Mirowska-Guzel D, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Péntek M.

Eur J Health Econ. 2019 Jun;20(Suppl 1):109-117. doi: 10.1007/s10198-019-01068-9. Epub 2019 May 16.

PMID:
31098882
8.

S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals.

Cerezo LA, Šumová B, Hulejová H, Štorkánová H, Szczuková L, Tomčík M, Bečvář R, Pavelka K, Vencovský J, Závada J, Šenolt L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):338-339. Epub 2019 Feb 4. No abstract available.

9.

Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry.

Mann HF, Závada J, Šenolt L, Bubová K, Nekvindová L, Křístková Z, Horák P, Vencovský J, Pavelka K; and the ATTRA Registry.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):342-343. Epub 2019 Jan 4. No abstract available.

10.

Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.

Šumová B, Cerezo LA, Szczuková L, Nekvindová L, Uher M, Hulejová H, Moravcová R, Grigorian M, Pavelka K, Vencovský J, Šenolt L, Závada J.

Rheumatol Int. 2019 Mar;39(3):469-478. doi: 10.1007/s00296-018-4190-2. Epub 2018 Nov 3.

PMID:
30392117
11.

The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different Methodologies.

Lee A, Sandvei M, Asmussen HC, Skougaard M, Macdonald J, Zavada J, Bliddal H, Taylor PC, Gudbergsen H.

JMIR Res Protoc. 2018 Jul 16;7(7):e165. doi: 10.2196/resprot.9521.

12.

Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.

Hurnakova J, Hulejova H, Zavada J, Komarc M, Cerezo LA, Mann H, Vencovsky J, Pavelka K, Senolt L.

Clin Rheumatol. 2018 Aug;37(8):2055-2062. doi: 10.1007/s10067-018-4091-5. Epub 2018 Apr 14.

PMID:
29656372
13.

EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.

Batóg P, Rencz F, Péntek M, Gulácsi L, Filipiak KJ, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Golicki D.

Kardiol Pol. 2018;76(5):860-870. doi: 10.5603/KP.a2018.0033. Epub 2018 Jan 19.

14.

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.

Radner H, Chatzidionysiou K, Nikiphorou E, Gossec L, Hyrich KL, Zabalan C, van Eijk-Hustings Y, Williamson PR, Balanescu A, Burmester GR, Carmona L, Dougados M, Finckh A, Haugeberg G, Hetland ML, Oliver S, Porter D, Raza K, Ryan P, Santos MJ, van der Helm-van Mil A, van Riel P, von Krause G, Zavada J, Dixon WG, Askling J.

Ann Rheum Dis. 2018 Apr;77(4):476-479. doi: 10.1136/annrheumdis-2017-212256. Epub 2018 Jan 4.

PMID:
29301783
15.

Functional non-synonymous variants of ABCG2 and gout risk.

Stiburkova B, Pavelcova K, Zavada J, Petru L, Simek P, Cepek P, Pavlikova M, Matsuo H, Merriman TR, Pavelka K.

Rheumatology (Oxford). 2017 Nov 1;56(11):1982-1992. doi: 10.1093/rheumatology/kex295.

PMID:
28968913
16.

EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.

Zrubka Z, Rencz F, Závada J, Golicki D, Rupel VP, Simon J, Brodszky V, Baji P, Petrova G, Rotar A, Gulácsi L, Péntek M.

Rheumatol Int. 2017 Dec;37(12):1957-1977. doi: 10.1007/s00296-017-3800-8. Epub 2017 Aug 28. Review.

PMID:
28849432
17.

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.

Hurnakova J, Hulejova H, Zavada J, Hanova P, Komarc M, Mann H, Klein M, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Vencovsky J, Pavelka K, Senolt L.

PLoS One. 2017 Aug 23;12(8):e0183420. doi: 10.1371/journal.pone.0183420. eCollection 2017.

18.

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, Dreyer L, Hetland ML, Cordtz R, Hyrich K, Strangfeld A, Zink A, Canhao H, Hernandez MV, Tubach F, Gottenberg JE, Morel J, Zavada J, Iannone F, Askling J, Listing J.

Ann Rheum Dis. 2017 Dec;76(12):2025-2030. doi: 10.1136/annrheumdis-2017-211623. Epub 2017 Aug 19.

19.

The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study.

Závada J, Hánová P, Hurňáková J, Szczuková L, Uher M, Forejtová Š, Klein M, Mann H, Olejárová M, Růžičková O, Šléglová O, Hejduk K, Pavelka K.

Arthritis Res Ther. 2017 Jan 13;19(1):5. doi: 10.1186/s13075-016-1208-6.

20.

Photoluminescence quantum efficiency of Er optical centers in GaN epilayers.

Ho VX, Dao TV, Jiang HX, Lin JY, Zavada JM, McGill SA, Vinh NQ.

Sci Rep. 2017 Jan 5;7:39997. doi: 10.1038/srep39997.

21.

Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.

Mišunová M, Svitálková T, Pleštilová L, Kryštufková O, Tegzová D, Svobodová R, Hušáková M, Tomčík M, Bečvář R, Závada J, Mann H, Kolesár L, Slavčev A, Vencovský J, Novota P.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):33-42. Epub 2016 Dec 28.

PMID:
28032847
22.

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.

Hurnakova J, Hulejova H, Zavada J, Komarc M, Hanova P, Klein M, Mann H, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Vencovsky J, Pavelka K, Senolt L.

PLoS One. 2016 Nov 10;11(11):e0165498. doi: 10.1371/journal.pone.0165498. eCollection 2016.

23.

EQ-5D in Central and Eastern Europe: 2000-2015.

Rencz F, Gulácsi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, Stolk EA, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Péntek M.

Qual Life Res. 2016 Nov;25(11):2693-2710. Epub 2016 Jul 29. Review.

PMID:
27472992
24.

2016 updated EULAR evidence-based recommendations for the management of gout.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Lioté F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T.

Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25. Review.

PMID:
27457514
25.

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers.

Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML, Strangfeld A, Zink A, Mariette X, Finckh A, Canhao H, Iannone F, Zavada J, Morel J, Gottenberg JE, Hyrich KL, Listing J.

Ann Rheum Dis. 2017 Feb;76(2):386-391. doi: 10.1136/annrheumdis-2016-209285. Epub 2016 Jun 15.

26.

Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

Pesickova SS, Rysava R, Lenicek M, Vitek L, Potlukova E, Hruskova Z, Jancova E, Honsova E, Zavada J, Trendelenburg M, Tesar V.

Arthritis Res Ther. 2015 Dec 24;17:371. doi: 10.1186/s13075-015-0879-8.

27.

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.

Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, Hulejová H, Tomčík M, Šenolt L, Vencovský J.

Arthritis Res Ther. 2015 Nov 25;17:341. doi: 10.1186/s13075-015-0862-4.

28.

Microarray analysis of circulating micro RNAs in the serum of patients with polymyositis and dermatomyositis reveals a distinct disease expression profile and is associated with disease activity.

Misunova M, Salinas-Riester G, Luthin S, Pommerenke C, Husakova M, Zavada J, Klein M, Plestilova L, Svitalkova T, Cepek P, Novota P, Vencovsky J.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):17-24. Epub 2015 Nov 17.

PMID:
26574749
29.

Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis.

Stiburkova B, Miyata H, Závada J, Tomčík M, Pavelka K, Storkanova G, Toyoda Y, Takada T, Suzuki H.

Rheumatology (Oxford). 2016 Jan;55(1):191-4. doi: 10.1093/rheumatology/kev350. Epub 2015 Sep 30. No abstract available.

PMID:
26428519
30.

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.

Hurnakova J, Zavada J, Hanova P, Hulejova H, Klein M, Mann H, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Komarc M, Vencovsky J, Pavelka K, Senolt L.

Arthritis Res Ther. 2015 Sep 15;17:252. doi: 10.1186/s13075-015-0764-5.

31.

High levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort.

Šenolt L, Cerezo LA, Šumová B, Pecha O, Pleštilová L, Forejtová Š, Růžičková O, Hušáková M, Závada J, Pavelka K, Vencovský J, Mann H.

Biomarkers. 2015 Feb;20(1):47-51. doi: 10.3109/1354750X.2014.989544. Epub 2014 Dec 9.

PMID:
25489637
32.

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers.

Kearsley-Fleet L, Závada J, Hetland ML, Nordström DC, Aaltonen KJ, Listing J, Zink A, Gati T, Rojkovich B, Iannone F, Gremese E, van Riel PLCM, van de Laar MAFJ, Lie E, Kvien TK, Canhão H, Fonseca JE, Rotar Ž, Loza E, Carmona L, Askling J, Johansson K, Finckh A, Dixon WG, Hyrich KL.

Rheumatology (Oxford). 2015 Jun;54(6):1074-1079. doi: 10.1093/rheumatology/keu446. Epub 2014 Nov 27.

PMID:
25433042
33.

A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study.

Závada J, Uher M, Sisol K, Forejtová Š, Jarošová K, Mann H, Vencovský J, Pavelka K.

Ann Rheum Dis. 2016 Jan;75(1):96-102. doi: 10.1136/annrheumdis-2014-205202. Epub 2014 Aug 27.

PMID:
25165033
34.

β-Catenin inactivation is a pre-requisite for chick retina regeneration.

Zhu J, Luz-Madrigal A, Haynes T, Zavada J, Burke AK, Del Rio-Tsonis K.

PLoS One. 2014 Jul 8;9(7):e101748. doi: 10.1371/journal.pone.0101748. eCollection 2014.

35.

Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.

Závada J, Sinikka Pesicková S, Rysavá R, Horák P, Hrncír Z, Lukác J, Rovensky J, Vítová J, Havrda M, Rychlík I, Böhmova J, Vlasáková V, Slatinská J, Zadrazil J, Olejárová M, Tegzova D, Tesar V.

Lupus. 2014;23(1):69-74. doi: 10.1177/0961203313511555. Epub 2013 Nov 8.

PMID:
24213308
36.

Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries.

Zavada J, Dixon WG, Askling J; EULAR Study group on Longitudinal Observational Registers and Drug Studies.

Ann Rheum Dis. 2014 Mar;73(3):628. doi: 10.1136/annrheumdis-2013-204102. Epub 2013 Sep 20. No abstract available.

PMID:
24058015
37.

Correlation between the optical loss and crystalline quality in erbium-doped GaN optical waveguides.

Feng IW, Zhao W, Li J, Lin J, Jiang H, Zavada J.

Appl Opt. 2013 Aug 1;52(22):5426-9. doi: 10.1364/AO.52.005426.

PMID:
23913061
38.

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.

Závada J, Lunt M, Davies R, Low AS, Mercer LK, Galloway JB, Watson KD, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium.

Ann Rheum Dis. 2014 Jan;73(1):252-5. doi: 10.1136/annrheumdis-2012-203102. Epub 2013 May 5.

PMID:
23644671
39.

Optical excitation cross section of erbium in GaN.

Feng IW, Li J, Lin J, Jiang H, Zavada J.

Appl Opt. 2013 Feb 20;52(6):1132-5. doi: 10.1364/AO.52.001132.

PMID:
23434981
40.

Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.

Ino Y, Yamazaki-Itoh R, Oguro S, Shimada K, Kosuge T, Zavada J, Kanai Y, Hiraoka N.

PLoS One. 2013;8(2):e55146. doi: 10.1371/journal.pone.0055146. Epub 2013 Feb 12.

41.

Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer.

Neumeister VM, Sullivan CA, Lindner R, Lezon-Geyda K, Li J, Zavada J, Martel M, Glazer PM, Tuck DP, Rimm DL, Harris L.

Breast Cancer Res Treat. 2012 Nov;136(1):67-75. doi: 10.1007/s10549-012-2232-0. Epub 2012 Sep 14.

PMID:
22976806
42.

Black mamba dendroaspis polylepis bite: a case report.

Závada J, Valenta J, Kopecký O, Stach Z, Leden P.

Prague Med Rep. 2011;112(4):298-304.

PMID:
22142525
43.

Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus.

Závada J, Nytrová P, Wandinger KP, Jarius S, Svobodová R, Probst C, Peterová V, Tegzová D, Pavelka K, Vencovský J.

Rheumatol Int. 2013 Jan;33(1):259-63. doi: 10.1007/s00296-011-2176-4. Epub 2011 Oct 29.

PMID:
22038193
44.

Mycobacterium marinum epididymoorchitis: case report and literature review.

Macek P, Bodnarova M, Zavada J, Jezek P, Pavlik I, Slany M, Havelkova M, Stork J, Duskova J, Hanus T, Kocvara R.

Urol Int. 2011;87(1):120-4. doi: 10.1159/000328220. Epub 2011 Jul 2. Review.

PMID:
21734351
45.

Clinical aspects of sepsis.

Holub M, Závada J.

Contrib Microbiol. 2011;17:12-30. doi: 10.1159/000323983. Epub 2011 Jun 9. Review.

PMID:
21659745
46.

Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation.

Hiraoka N, Ino Y, Sekine S, Tsuda H, Shimada K, Kosuge T, Zavada J, Yoshida M, Yamada K, Koyama T, Kanai Y.

Br J Cancer. 2010 Sep 28;103(7):1057-65. doi: 10.1038/sj.bjc.6605854. Epub 2010 Aug 24.

47.

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.

Zavada J, Pesickova S, Rysava R, Olejarova M, Horák P, Hrncír Z, Rychlík I, Havrda M, Vítova J, Lukác J, Rovensky J, Tegzova D, Böhmova J, Zadrazil J, Hána J, Dostál C, Tesar V.

Lupus. 2010 Oct;19(11):1281-9. doi: 10.1177/0961203310371155. Epub 2010 Jul 6.

PMID:
20605876
48.

A comparison of three methods to estimate baseline creatinine for RIFLE classification.

Závada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, Bellomo R, Kellum JA; AKI6 investigators.

Nephrol Dial Transplant. 2010 Dec;25(12):3911-8. doi: 10.1093/ndt/gfp766. Epub 2010 Jan 25.

PMID:
20100732
49.

Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up.

Hruskova Z, Rihova Z, Mareckova H, Jancova E, Rysava R, Zavada J, Merta M, Löster T, Tesar V.

Arch Med Res. 2009 May;40(4):276-84. doi: 10.1016/j.arcmed.2009.04.001.

PMID:
19608017
50.

Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Závada J, Kideryová L, Pytlík R, Hrusková Z, Tesar V.

Rheumatology (Oxford). 2009 Oct;48(10):1197-201. doi: 10.1093/rheumatology/kep130. Epub 2009 Jun 9.

PMID:
19509188

Supplemental Content

Loading ...
Support Center